Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 50

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer

Zick, Suzanna M., Turgeon, D. Kim, Vareed, Shaiju K., Ruffin, Mack T., Litzinger, Amie J., Wright, Benjamin D., Alrawi, Sara, Normolle, Daniel P., Djuric, Zora, Brenner, Dean E. · 2011 · Cancer Prevention Research

Abstract

Inhibitors of COX indicate that upregulation of inflammatory eicosanoids produced by COX, and in particular prostaglandin E2 (PGE2), are early events in the development of colorectal cancer (CRC). Ginger has shown downregulation of COX in vitro and decreased incidence/multiplicity of adenomas in rats. This study was conducted to determine if 2.0 g/d of ginger could decrease the levels of PGE2, 13-hydroxy-octadecadienoic acids, and 5-, 12-, and 15-hydroxyeicosatetraenoic acid (5-, 12-, and 15-HETE), in the colon mucosa of healthy volunteers. To investigate this aim, we randomized 30 subjects to 2.0 g/d ginger or placebo for 28 days. Flexible sigmoidoscopy at baseline and day 28 was used to obtain colon biopsies. A liquid chromatography mass spectrometry method was used to determine eicosanoid levels in the biopsies, and levels were expressed per protein or per free arachidonic acid. There were no significant differences in mean percent change between baseline and day 28 for any of the eicosanoids, when normalized to protein. There was a significant decrease in mean percent change in PGE2 (P = 0.05) and 5-HETE (P = 0.04), and a trend toward significant decreases in 12-HETE (P = 0.09) and 15-HETE (P = 0.06) normalized to free arachidonic acid. There was no difference between the groups in terms of total adverse events P = 0.55). On the basis of these results, it seems that ginger has the potential to decrease eicosanoid levels, perhaps by inhibiting their synthesis from arachidonic acid. Ginger also seemed to be tolerable and safe. Further investigation in people at high risk for CRC seems warranted. Cancer Prev Res; 4(11); 1929–37. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1940-6207.capr-11-0224

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 41

  1. Elwood, 2009, Aspirin, salicylates, and cancer, Lancet, 373, 1301, 10.1016/S0140-6736(09)60243-9 · DOI · Paper page
  2. Cianchi, 2004, Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer, Clin Cancer Res, 10, 2694, 10.1158/1078-0432.CCR-03-0192 · DOI
  3. Pidgeon, 2007, Lipoxygenase metabolism: roles in tumor progression and survival, Cancer Metastasis Rev, 26, 503, 10.1007/s10555-007-9098-3 · DOI · Paper page
  4. Ye, 2005, Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke, Carcinogenesis, 26, 827, 10.1093/carcin/bgi012 · DOI
  5. Melstrom, 2008, Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model, Clin Cancer Res, 14, 6525, 10.1158/1078-0432.CCR-07-4631 · DOI
  6. Soumaoro, 2006, Expression of 5-lipoxygenase in human colorectal cancer, World J Gastroenterol, 12, 6355, 10.3748/wjg.v12.i39.6355 · doi:10.3748/wjg.v12.i39.6355
  7. Tong, 2005, LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways, Biochem Biophys Res Commun, 335, 949, 10.1016/j.bbrc.2005.07.166 · DOI
  8. Bortuzzo, 1996, The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells, Biochim Biophys Acta, 1300, 240, 10.1016/0005-2760(96)00003-3 · DOI
  9. Nielsen, 2005, A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells, Cancer Res, 65, 732, 10.1158/0008-5472.732.65.3 · DOI
  10. Bhattacharya, 15-Lipoxygenase-1 in colorectal cancer: a review, Tumor Biol 2009, 30, 185, 10.1159/000236864 · DOI
  11. Shureiqi, 2010, Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis, Cancer Prev Res, 3, 829, 10.1158/1940-6207.CAPR-09-0110 · DOI
  12. Surh, 1998, Chemoprotective properties of some pungent ingredients present in red pepper and ginger, Mut Res, 402, 259, 10.1016/S0027-5107(97)00305-9 · DOI
  13. Koo, 2001, Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation, Thrombosis Res, 103, 387, 10.1016/S0049-3848(01)00338-3 · DOI
  14. Kiuchi, 1982, Inhibitors of prostaglandin biosynthesis from ginger, Chem Pharma Bull (Tokyo), 30, 754, 10.1248/cpb.30.754 · DOI
  15. Mascolo, 1989, Ethnopharmacologic investigation of ginger (Zingiber officinale), J Ethnopharmacology, 27, 129, 10.1016/0378-8741(89)90085-8 · DOI · Paper page
  16. Sharma, 1994, Suppressive effects of eugenol and ginger oil on arthritic rats, Pharmacology, 49, 314, 10.1159/000139248 · DOI · Paper page
  17. Tjendraputra, 2001, Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells, Bioorganic Chem, 29, 156, 10.1006/bioo.2001.1208 · DOI · Paper page
  18. Kiuchi, 1992, Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids, Chem Pharma Bull (Tokyo), 40, 387, 10.1248/cpb.40.387 · DOI · Paper page
  19. Nurtjahja-Tjendraputra, 2003, Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger, Thromb Res, 111, 259, 10.1016/j.thromres.2003.09.009 · DOI · Paper page
  20. Park, 1998, Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice, Cancer Lett, 129, 139, 10.1016/S0304-3835(98)00081-0 · DOI · Paper page
  21. Suekawa, 1986, Pharmacological studies on ginger. II. Pressor action of (6)-shogaol in anesthetized rats, or hindquarters, tail and mesenteric vascular beds of rats, J Pharmacobiodyn, 9, 842, 10.1248/bpb1978.9.842 · DOI
  22. Ojewole, 2006, Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats, Phytother Res, 20, 764, 10.1002/ptr.1952 · DOI · Paper page
  23. Yoshimi, 1992, Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats, Jpn J Cancer Res, 83, 1273, 10.1111/j.1349-7006.1992.tb02758.x · DOI
  24. Manju, 2005, Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1,2 dimethylhydrazine-induced colon cancer, Clinica Chimica Acta, 358, 60, 10.1016/j.cccn.2005.02.018 · DOI · Paper page
  25. Kim, 2009, Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice, Int J Cancer, 124, 264, 10.1002/ijc.23923 · DOI · Paper page
  26. Dias, 2006, Lack of chemopreventive effects of ginger on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats, Food Chem Toxicol, 44, 877, 10.1016/j.fct.2005.11.015 · doi:10.1016/j.fct.2005.11.015
  27. Zick, 2008, Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects, Cancer Epidemiol Biomarkers Prev, 17, 1930, 10.1158/1055-9965.EPI-07-2934 · DOI · Paper page
  28. Vareed, 2008, Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects, Cancer Epidemiol Biomarkers Prev, 17, 1411, 10.1158/1055-9965.EPI-07-2693 · DOI · Paper page
  29. Yang, 2006, Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids, Prostaglandins Leukot Essent Fatty Acids, 75, 385, 10.1016/j.plefa.2006.07.015 · DOI
  30. Buczynski, 2007, TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells, J Biol Chem, 282, 22834, 10.1074/jbc.M701831200 · DOI
  31. Krishnan, 2001, Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer, Cancer Epidemiol Biomarkers Prev, 10, 447
  32. Frommel, 1997, Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients, Clin Cancer Res, 3, 209
  33. Barnes, 1999, Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon, Cancer Epidemiol Biomarkers Prev, 8, 311
  34. Ruffin, 1997, Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose, J Natl Cancer Inst, 89, 1152, 10.1093/jnci/89.15.1152 · doi:10.1093/jnci/89.15.1152
  35. Venerito, 2006, Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection, Aliment Pharmacol Ther, 23, 1225, 10.1111/j.1365-2036.2006.02856.x · doi:10.1111/j.1365-2036.2006.02856.x
  36. Giardiello, 2004, Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis, Gastroenterology, 126, 425, 10.1053/j.gastro.2003.11.013 · DOI
  37. Thompson, 2010, Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma, Gastroenterology, 139, 797, 10.1053/j.gastro.2010.06.005 · DOI
  38. Abrahamson, 2007, No effect of exercise on colon mucosal prostaglandin concentrations: a 12-month randomized controlled trial, Cancer Epidemiol Biomarkers Prev, 16, 2351, 10.1158/1055-9965.EPI-07-0120 · doi:10.1158/1055-9965.epi-07-0120
  39. Poole, 2010, Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma, Cancer Epidemiol Biomarkers Prev, 19, 547, 10.1158/1055-9965.EPI-09-0869 · DOI
  40. Yu, 2011, Examination of the pharmacokinetics of active ingredients of ginger in humans, AAPS J, 13, 417, 10.1208/s12248-011-9286-5 · DOI
  41. Lim, 2010, Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer, Yonsei Med J, 51, 692, 10.3349/ymj.2010.51.5.692 · DOI

Cited by

See all 50

Metadata

Authors
Zick, S. M., Turgeon, D. K., Vareed, S. K., Ruffin, M. T., Litzinger, A. J., Wright, B. D., Alrawi, S., Normolle, D. P., Djuric, Z., & Brenner, D. E.
Affiliations
Authors' Affiliations: Departments of 1Family Medicine, 2Internal Medicine, and 3Pharmacology, University of Michigan Medical School; 4VA Medical Center, Ann Arbor, Michigan; 5Department of Biostatistics, University of Pittsburgh, Pennsylvania; and 6Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
Venue
Cancer Prevention Research
Published
2011-11-01
Volume
4
Issue
11
Pages
1929-1937
ISSN
  • 1940-6207
  • 1940-6215
Cited by
50
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer. https://app.cochat.ai/papers/10.1158/1940-6207.capr-11-0224
The paper
Zick, S. M., Turgeon, D. K., Vareed, S. K., Ruffin, M. T., Litzinger, A. J., Wright, B. D., Alrawi, S., Normolle, D. P., Djuric, Z., & Brenner, D. E. (2011). Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer. Cancer Prevention Research. https://doi.org/10.1158/1940-6207.capr-11-0224

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.